427 related articles for article (PubMed ID: 27190325)
1. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
Wu M; Gu J; Mei S; Xu D; Jing Y; Yao Q; Chen M; Yang M; Chen S; Yang B; Qi N; Hu H; Wüthrich RP; Mei C
Nephrol Dial Transplant; 2016 Nov; 31(11):1826-1834. PubMed ID: 27190325
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol induces nuclear factor-κB activity in human cardiac cells.
Palomer X; Capdevila-Busquets E; Alvarez-Guardia D; Barroso E; Pallàs M; Camins A; Davidson MM; Planavila A; Villarroya F; Vázquez-Carrera M
Int J Cardiol; 2013 Sep; 167(6):2507-16. PubMed ID: 22748497
[TBL] [Abstract][Full Text] [Related]
3. Inflammation Is More Sensitive than Cell Proliferation in Response to Rapamycin Treatment in Polycystic Kidney Disease.
Yang M; Lv J; Gong C; Xue C; Fu L; Chen S; Mei C
Kidney Blood Press Res; 2024; 49(1):60-68. PubMed ID: 38167222
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
[TBL] [Abstract][Full Text] [Related]
5. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.
Cowley BD; Ricardo SD; Nagao S; Diamond JR
Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583
[TBL] [Abstract][Full Text] [Related]
6. Different short- and long-term effects of resveratrol on nuclear factor-kappaB phosphorylation and nuclear appearance in human endothelial cells.
Pellegatta F; Bertelli AA; Staels B; Duhem C; Fulgenzi A; Ferrero ME
Am J Clin Nutr; 2003 May; 77(5):1220-8. PubMed ID: 12716675
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol increases nephrin and podocin expression and alleviates renal damage in rats fed a high-fat diet.
Pan QR; Ren YL; Zhu JJ; Hu YJ; Zheng JS; Fan H; Xu Y; Wang G; Liu WX
Nutrients; 2014 Jul; 6(7):2619-31. PubMed ID: 25025298
[TBL] [Abstract][Full Text] [Related]
8. Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease.
Su Z; Wang X; Gao X; Liu Y; Pan C; Hu H; Beyer RP; Shi M; Zhou J; Zhang J; Serra AL; Wüthrich RP; Mei C
J Intern Med; 2014 Nov; 276(5):470-85. PubMed ID: 24494798
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy.
Kumar A; Sharma SS
Biochem Biophys Res Commun; 2010 Apr; 394(2):360-5. PubMed ID: 20211601
[TBL] [Abstract][Full Text] [Related]
10. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
[TBL] [Abstract][Full Text] [Related]
11. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL
Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol enhances TNF-α production in human monocytes upon bacterial stimulation.
Gualdoni GA; Kovarik JJ; Hofer J; Dose F; Pignitter M; Doberer D; Steinberger P; Somoza V; Wolzt M; Zlabinger GJ
Biochim Biophys Acta; 2014 Jan; 1840(1):95-105. PubMed ID: 24035785
[TBL] [Abstract][Full Text] [Related]
13. Effects of pyrrolidine dithiocarbamate on proliferation and nuclear factor-κB activity in autosomal dominant polycystic kidney disease cells.
Ta MH; Liuwantara D; Rangan GK
BMC Nephrol; 2015 Dec; 16():212. PubMed ID: 26666710
[TBL] [Abstract][Full Text] [Related]
14. An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease.
Ravichandran K; Zafar I; Ozkok A; Edelstein CL
Nephrol Dial Transplant; 2015 Jan; 30(1):45-53. PubMed ID: 25239638
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo.
He D; Guo Z; Pu JL; Zheng DF; Wei XF; Liu R; Tang CY; Wu ZJ
Int Immunopharmacol; 2016 Jun; 35():201-209. PubMed ID: 27064547
[TBL] [Abstract][Full Text] [Related]
16. Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway.
Jia Z; Nallasamy P; Liu D; Shah H; Li JZ; Chitrakar R; Si H; McCormick J; Zhu H; Zhen W; Li Y
J Nutr Biochem; 2015 Mar; 26(3):293-302. PubMed ID: 25577468
[TBL] [Abstract][Full Text] [Related]
17. The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activation.
Cui L; Feng L; Zhang ZH; Jia XB
Int Immunopharmacol; 2014 Nov; 23(1):294-303. PubMed ID: 25239813
[TBL] [Abstract][Full Text] [Related]
18. TRAF3 delays cyst formation induced by NF-κB signaling.
Sun L; Hu C; Zhang X
IUBMB Life; 2017 Mar; 69(3):170-178. PubMed ID: 28185403
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of NF-kappaB activity by resveratrol in cytokine-exposed mesangial cells.
Uchida Y; Yamazaki H; Watanabe S; Hayakawa K; Meng Y; Hiramatsu N; Kasai A; Yamauchi K; Yao J; Kitamura M
Clin Exp Immunol; 2005 Oct; 142(1):76-83. PubMed ID: 16178859
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
